Pharmaceuticals & Biotechnology (4570)

21,307.63
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

Haleon raises FY operating profit outlook, pares back organic revenue guidance

By Iain Gilbert

Date: Thursday 31 Jul 2025

(Sharecast News) - Consumer healthcare company Haleon hiked its interim dividend and raised its FY profit outlook on Wednesday after posting increased adjusted operating profits for H1, driven by productivity gains and margin expansion, but pared back its organic revenue growth forecast.

Pharmaceuticals & Biotechnology Regulatory News

Holding(s) in Company 31-Jul-2025 17:33 RNS
Holding(s) in Company 31-Jul-2025 17:28 RNS
Total Voting Rights 31-Jul-2025 16:30 RNS
Holding(s) in Company 31-Jul-2025 15:24 RNS
Interim Results for the 12 months to 31 March 2025 31-Jul-2025 12:30 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 21,307.63
Closing Price Change -395.95
% Change -1.82 %
31-Jul-25 Close 21,307.63

Top Risers

Price Change
TCF 0.25p +10.2%
SVNS 0.32p +5.9%
CIZ 1.63p +4.8%
APTA 0.35p +2.9%
4BB 990.00p +2.1%
N4P 0.46p +1.0%
GNS 2,495.00p +0.6%
PRTC 145.00p +0.1%
HIK 1,997.00p +0.1%
ONT 202.40p +0.1%

Top Fallers

Price Change
GENF 0.72p -11.8%
FARN 182.81p -7.2%
AVCT 49.33p -6.9%
AGY 8.00p -4.8%
SAR 16.33p -3.9%
VRCI 0.53p -3.0%
EDEN 3.30p -2.9%
VAL 0.58p -2.8%
HLN 357.10p -2.1%
OXB 450.50p -1.7%

Top of Page